45 CFR § 180 compliance
B · 80
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,510
Insurances with rates
0
CPT / HCPCS codes
2,450
Source MRF
Most expensive procedures (gross)
J9228
$61,467
IPILIMUMAB 200 MG/40ML IV SOLN
Gross
$94,564
MS DRG V39 (FY2022) 281
$55,375
Acute Myocardial Infarction, Discharged Alive With Cc
Gross
$85,192
MS DRG V39 (FY2022) 552
$46,263
Medical Back Problems Without McC
Gross
$71,174
MS DRG V39 (FY2022) 560
$42,600
Aftercare, Musculoskeletal System And Connective Tissue With Cc
Gross
$65,538
MS DRG V39 (FY2022) 155
$33,117
Other Ear, Nose, Mouth And Throat Diagnoses With Cc
Gross
$50,950
MS DRG V39 (FY2022) 057
$32,897
Degenerative Nervous System Disorders Without McC
Gross
$50,612
MS DRG V39 (FY2022) 950
$31,583
Aftercare Without Cc/McC
Gross
$48,589
MS DRG V39 (FY2022) 439
$28,862
Disorders Of Pancreas Except Malignancy With Cc
Gross
$44,404
MS DRG V39 (FY2022) 283
$27,798
Acute Myocardial Infarction, Expired With McC
Gross
$42,766
MS DRG V39 (FY2022) 184
$23,811
Major Chest Trauma With Cc
Gross
$36,632
J9043
$22,720
CABAZITAXEL 60 MG/1.5 ML IV SOLN DILUTED TO 10 MG/ML
Gross
$34,954
MS DRG V39 (FY2022) 535
$22,656
Fractures Of Hip And Pelvis With McC
Gross
$34,855
MS DRG V39 (FY2022) 391
$21,189
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders With McC
Gross
$32,598
MS DRG V39 (FY2022) 951
$20,282
Other Factors Influencing Health Status
Gross
$31,203
J9042
$19,261
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$29,632
J9022
$18,860
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$29,016
J1932
$18,275
LANREOTIDE ACETATE 120 MG/0.5ML SC SOLN
Gross
$28,115
MS DRG V39 (FY2022) 309
$17,830
Cardiac Arrhythmia And Conduction Disorders With Cc
Gross
$27,431
MS DRG V39 (FY2022) 947
$16,687
Signs And Symptoms With McC
Gross
$25,672
J9144
$16,677
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$25,657
37228
$15,988
Revsc Opn/Prq Tib/Pero W/Angioplasty Uni
Gross
$24,597
J3380
$14,742
VEDOLIZUMAB 300 MG IV SOLR
Gross
$22,679
MS DRG V39 (FY2022) 999
$14,616
Ungroupable
Gross
$22,487
MS DRG V39 (FY2022) 638
$14,616
Diabetes With Cc
Gross
$22,487
MS DRG V39 (FY2022) 559
$14,522
Aftercare, Musculoskeletal System And Connective Tissue With McC
Gross
$22,341
MS DRG V39 (FY2022) 202
$14,439
Bronchitis And Asthma With Cc/McC
Gross
$22,214
J9301
$13,953
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$21,467
MS DRG V39 (FY2022) 441
$13,717
Disorders Of Liver Except Malignancy, Cirrhosis Or Alcoholic Hepatitis With McC
Gross
$21,102
MS DRG V39 (FY2022) 690
$13,655
Kidney And Urinary Tract Infections Without McC
Gross
$21,008
MS DRG V39 (FY2022) 561
$13,348
Aftercare, Musculoskeletal System And Connective Tissue Without Cc/McC
Gross
$20,535
MS DRG V39 (FY2022) 378
$13,268
Gastrointestinal Hemorrhage With Cc
Gross
$20,412
MS DRG V39 (FY2022) 689
$12,999
Kidney And Urinary Tract Infections With McC
Gross
$19,998
MS DRG V39 (FY2022) 639
$12,835
Diabetes Without Cc/McC
Gross
$19,746
MS DRG V39 (FY2022) 871
$12,796
Septicemia Or Severe Sepsis Without Mv >96 Hours With McC
Gross
$19,686
MS DRG V39 (FY2022) 065
$12,749
Intracranial Hemorrhage Or Cerebral Infarction With Cc Or Tpa In 24 Hours
Gross
$19,613
MS DRG V39 (FY2022) 156
$12,668
Other Ear, Nose, Mouth And Throat Diagnoses Without Cc/McC
Gross
$19,489
37221
$12,643
Revsc Opn/Prq Iliac Art W/Stnt Plmt & Angioplsty
Gross
$19,450
J9308
$12,613
RAMUCIRUMAB 500 MG/50ML IV SOLN
Gross
$19,404
55874
$12,411
Transperineal Plmt Biodegradable Matrl 1/Mlt Njx
Gross
$19,094
J2506
$12,266
PEGFILGRASTIM 6 MG/0.6ML SC SOSY
Gross
$18,871
MS DRG V39 (FY2022) 293
$12,149
Heart Failure And Shock Without Cc/McC
Gross
$18,690
MS DRG V39 (FY2022) 291
$12,149
Heart Failure And Shock With McC
Gross
$18,690
69706
$12,091
Surg Nasopharyngoscopy Dilat Eustachian Tube Bi
Gross
$18,602
30468
$11,520
Rpr Nsl Vlv Collapse Subq/Sbmcsl Lat Wall Implt
Gross
$17,723
MS DRG V39 (FY2022) 897
$11,481
Alcohol, Drug Abuse Or Dependence Without Rehabilitation Therapy Without McC
Gross
$17,663
MS DRG V39 (FY2022) 190
$11,415
Chronic Obstructive Pulmonary Disease With McC
Gross
$17,562
J9306
$11,272
PERTUZUMAB 420 MG/14ML IV SOLN
Gross
$17,342
MS DRG V39 (FY2022) 544
$10,449
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy Without Cc/McC
Gross
$16,076
37191
$10,226
Ins Intrvas Vc Filtr W/WO Vas Acs Vsl Selxn Rs&I
Gross
$15,732
J9271
$10,209
PEMBROLIZUMAB 100 MG/4ML IV SOLN
Gross
$15,706
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9228 | IPILIMUMAB 200 MG/40ML IV SOLN | $94,564 | $61,467 | $58,923 | $94,564 | 0 |
| MS DRG V39 (FY2022) 281 | Acute Myocardial Infarction, Discharged Alive With Cc | $85,192 | $55,375 | $53,083 | $85,192 | 0 |
| MS DRG V39 (FY2022) 552 | Medical Back Problems Without McC | $71,174 | $46,263 | $44,348 | $71,174 | 0 |
| MS DRG V39 (FY2022) 560 | Aftercare, Musculoskeletal System And Connective Tissue With Cc | $65,538 | $42,600 | $40,837 | $65,538 | 0 |
| MS DRG V39 (FY2022) 155 | Other Ear, Nose, Mouth And Throat Diagnoses With Cc | $50,950 | $33,117 | $31,747 | $50,950 | 0 |
| MS DRG V39 (FY2022) 057 | Degenerative Nervous System Disorders Without McC | $50,612 | $32,897 | $31,536 | $50,612 | 0 |
| MS DRG V39 (FY2022) 950 | Aftercare Without Cc/McC | $48,589 | $31,583 | $30,276 | $48,589 | 0 |
| MS DRG V39 (FY2022) 439 | Disorders Of Pancreas Except Malignancy With Cc | $44,404 | $28,862 | $27,668 | $44,404 | 0 |
| MS DRG V39 (FY2022) 283 | Acute Myocardial Infarction, Expired With McC | $42,766 | $27,798 | $26,647 | $42,766 | 0 |
| MS DRG V39 (FY2022) 184 | Major Chest Trauma With Cc | $36,632 | $23,811 | $22,825 | $36,632 | 0 |
| J9043 | CABAZITAXEL 60 MG/1.5 ML IV SOLN DILUTED TO 10 MG/ML | $34,954 | $22,720 | $21,780 | $34,954 | 0 |
| MS DRG V39 (FY2022) 535 | Fractures Of Hip And Pelvis With McC | $34,855 | $22,656 | $21,718 | $34,855 | 0 |
| MS DRG V39 (FY2022) 391 | Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders With McC | $32,598 | $21,189 | $20,312 | $32,598 | 0 |
| MS DRG V39 (FY2022) 951 | Other Factors Influencing Health Status | $31,203 | $20,282 | $19,442 | $31,203 | 0 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $29,632 | $19,261 | $18,464 | $29,632 | 0 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $29,016 | $18,860 | $18,080 | $29,016 | 0 |
| J1932 | LANREOTIDE ACETATE 120 MG/0.5ML SC SOLN | $28,115 | $18,275 | $17,519 | $28,115 | 0 |
| MS DRG V39 (FY2022) 309 | Cardiac Arrhythmia And Conduction Disorders With Cc | $27,431 | $17,830 | $17,092 | $27,431 | 0 |
| MS DRG V39 (FY2022) 947 | Signs And Symptoms With McC | $25,672 | $16,687 | $15,996 | $25,672 | 0 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $25,657 | $16,677 | $15,987 | $25,657 | 0 |
| 37228 | Revsc Opn/Prq Tib/Pero W/Angioplasty Uni | $24,597 | $15,988 | $488 | $26,427 | 0 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $22,679 | $14,742 | $14,131 | $22,679 | 0 |
| MS DRG V39 (FY2022) 999 | Ungroupable | $22,487 | $14,616 | $14,011 | $22,487 | 0 |
| MS DRG V39 (FY2022) 638 | Diabetes With Cc | $22,487 | $14,616 | $14,011 | $22,487 | 0 |
| MS DRG V39 (FY2022) 559 | Aftercare, Musculoskeletal System And Connective Tissue With McC | $22,341 | $14,522 | $13,921 | $22,341 | 0 |
| MS DRG V39 (FY2022) 202 | Bronchitis And Asthma With Cc/McC | $22,214 | $14,439 | $13,841 | $22,214 | 0 |
| J9301 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $21,467 | $13,953 | $13,376 | $21,467 | 0 |
| MS DRG V39 (FY2022) 441 | Disorders Of Liver Except Malignancy, Cirrhosis Or Alcoholic Hepatitis With McC | $21,102 | $13,717 | $13,149 | $21,102 | 0 |
| MS DRG V39 (FY2022) 690 | Kidney And Urinary Tract Infections Without McC | $21,008 | $13,655 | $13,090 | $21,008 | 0 |
| MS DRG V39 (FY2022) 561 | Aftercare, Musculoskeletal System And Connective Tissue Without Cc/McC | $20,535 | $13,348 | $12,796 | $20,535 | 0 |
| MS DRG V39 (FY2022) 378 | Gastrointestinal Hemorrhage With Cc | $20,412 | $13,268 | $12,718 | $20,412 | 0 |
| MS DRG V39 (FY2022) 689 | Kidney And Urinary Tract Infections With McC | $19,998 | $12,999 | $12,461 | $19,998 | 0 |
| MS DRG V39 (FY2022) 639 | Diabetes Without Cc/McC | $19,746 | $12,835 | $12,304 | $19,746 | 0 |
| MS DRG V39 (FY2022) 871 | Septicemia Or Severe Sepsis Without Mv >96 Hours With McC | $19,686 | $12,796 | $12,266 | $19,686 | 0 |
| MS DRG V39 (FY2022) 065 | Intracranial Hemorrhage Or Cerebral Infarction With Cc Or Tpa In 24 Hours | $19,613 | $12,749 | $12,221 | $19,613 | 0 |
| MS DRG V39 (FY2022) 156 | Other Ear, Nose, Mouth And Throat Diagnoses Without Cc/McC | $19,489 | $12,668 | $12,144 | $19,489 | 0 |
| 37221 | Revsc Opn/Prq Iliac Art W/Stnt Plmt & Angioplsty | $19,450 | $12,643 | $444 | $22,550 | 0 |
| J9308 | RAMUCIRUMAB 500 MG/50ML IV SOLN | $19,404 | $12,613 | $12,091 | $19,404 | 0 |
| 55874 | Transperineal Plmt Biodegradable Matrl 1/Mlt Njx | $19,094 | $12,411 | $157 | $19,094 | 0 |
| J2506 | PEGFILGRASTIM 6 MG/0.6ML SC SOSY | $18,871 | $12,266 | $11,758 | $18,871 | 0 |
| MS DRG V39 (FY2022) 293 | Heart Failure And Shock Without Cc/McC | $18,690 | $12,149 | $11,646 | $18,690 | 0 |
| MS DRG V39 (FY2022) 291 | Heart Failure And Shock With McC | $18,690 | $12,149 | $11,646 | $18,690 | 0 |
| 69706 | Surg Nasopharyngoscopy Dilat Eustachian Tube Bi | $18,602 | $12,091 | $227 | $18,602 | 0 |
| 30468 | Rpr Nsl Vlv Collapse Subq/Sbmcsl Lat Wall Implt | $17,723 | $11,520 | $157 | $17,723 | 0 |
| MS DRG V39 (FY2022) 897 | Alcohol, Drug Abuse Or Dependence Without Rehabilitation Therapy Without McC | $17,663 | $11,481 | $11,006 | $17,663 | 0 |
| MS DRG V39 (FY2022) 190 | Chronic Obstructive Pulmonary Disease With McC | $17,562 | $11,415 | $10,943 | $17,562 | 0 |
| J9306 | PERTUZUMAB 420 MG/14ML IV SOLN | $17,342 | $11,272 | $10,806 | $17,342 | 0 |
| MS DRG V39 (FY2022) 544 | Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy Without Cc/McC | $16,076 | $10,449 | $10,017 | $16,076 | 0 |
| 37191 | Ins Intrvas Vc Filtr W/WO Vas Acs Vsl Selxn Rs&I | $15,732 | $10,226 | $207 | $15,732 | 0 |
| J9271 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $15,706 | $10,209 | $9,787 | $15,706 | 0 |
Showing top 50 of 2,510 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.